Catalysts for Teva Pharmaceuticals USA Inc
453 tracked
Apr 17, 2020
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Nov 25, 2019
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 7, 2019
approval
MORPHINE SULFATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 7, 2019
approval
FENTORA (FENTANYL CITRATE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 7, 2019
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 7, 2019
approval
ACTIQ (FENTANYL CITRATE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Sep 12, 2019
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Sep 12, 2019
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
May 30, 2019
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
May 30, 2019
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Jan 16, 2019
approval
CLOZAPINE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Jan 16, 2019
approval
CLOZAPINE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Jan 14, 2019
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Nov 30, 2018
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 31, 2018
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Oct 16, 2018
approval
OXALIPLATIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Sep 18, 2018
approval
MORPHINE SULFATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Sep 18, 2018
approval
MORPHINE SULFATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Sep 18, 2018
approval
MORPHINE SULFATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Sep 18, 2018
approval
MORPHINE SULFATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Sep 18, 2018
approval
MORPHINE SULFATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Aug 31, 2018
approval
CLARAVIS (ISOTRETINOIN) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Aug 31, 2018
approval
CLARAVIS (ISOTRETINOIN) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Jul 19, 2018
approval
MORPHINE SULFATE โ FDA approval
Teva Pharmaceuticals USA Inc
โ
May 2, 2018
approval
CLARAVIS (ISOTRETINOIN) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
May 2, 2018
approval
CLARAVIS (ISOTRETINOIN) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Apr 23, 2018
approval
CLARAVIS (ISOTRETINOIN) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Apr 23, 2018
approval
CLARAVIS (ISOTRETINOIN) โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Apr 23, 2018
approval
VIGABATRIN โ FDA approval
Teva Pharmaceuticals USA Inc
โ
Feb 1, 2018
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
Teva Pharmaceuticals USA Inc
โ